Affiliation:
1. Hospital Sant PauIIB-Sant Pau, Research Center for Pituitary Diseases, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unidad 747), ISCIII, and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
Abstract
Background
In the last few years, quality of life (QoL) has become an outcome measure in patients with pituitary diseases.
Objective
To describe the available data on QoL impairment evaluated with questionnaires in patients with pituitary diseases.
Design
Critical review of the pertinent literature and pragmatic discussion of available information.
Methods
Selection of relevant literature from PubMed and WOK, especially from the last 5 years and comprehensive analysis.
Results
QoL is impaired in all pituitary diseases, mostly in acromegaly and Cushing’s disease (similar to other causes of Cushing’s syndrome), but also in non-functioning pituitary adenomas and prolactinomas, especially in the active phase of the disease. Nevertheless, even after endocrine ‘cure’, scores tend to be below normative values, indicative of residual morbidity after hormonal control. The presence of hypopituitarism worsens subjective QoL perception, which can improve after optimal substitution therapy, including recombinant human growth hormone, when indicated.
Conclusions
To improve the long-term outcome of pituitary patients, helping them to attain the best possible health, it appears desirable to include subjective aspects captured when evaluating QoL, so that the affected dimensions are identified and if relevant treated. Additionally, being aware that treatment outcome may not always mean complete normalisation of physical and mental issues related to QoL can be a first step to adaptation and conforming to this new status.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference82 articles.
1. The chronic syndromes after previous treatment of pituitary tumours;Romijn;Nature Reviews Endocrinology,2016
2. Coping with ‘cured’ pituitary tumors;Webb;Nature Reviews Endocrinology,2011
3. Schipper H Clinch JJ Olweny CLM. Quality of life studies: definitions and conceptual issues. In Quality of Life Assessments in Clinical Trials, p 16. Ed Spilker B . New York: Raven Press Ltd, 1990.
4. Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnosis process;Flitsch;Experimental and Clinical Endocrinology and Diabetes,2000
5. Psychosocial impairment in patients treated for pituitary disease: a controlled study
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献